0001209191-20-021848.txt : 20200331 0001209191-20-021848.hdr.sgml : 20200331 20200331170108 ACCESSION NUMBER: 0001209191-20-021848 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200330 FILED AS OF DATE: 20200331 DATE AS OF CHANGE: 20200331 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOZE BARRY CENTRAL INDEX KEY: 0001619500 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 20762581 MAIL ADDRESS: STREET 1: C/O HORIZON PHARMA, INC. STREET 2: 520 EAST COOK ROAD, SUITE 520 CITY: DEERFIELD STATE: IL ZIP: 60015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-30 0 0001492426 Horizon Therapeutics Public Ltd Co HZNP 0001619500 MOZE BARRY C/O HORIZON THERAPEUTICS PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 4 IRELAND 0 1 0 0 EVP, Chief Admin. Officer Ordinary Shares 2020-03-30 4 M 0 2106 12.94 A 168397 D Ordinary Shares 2020-03-30 4 S 0 2106 28.18 D 166291 D Stock Option (Right to Buy) 12.94 2020-03-30 4 M 0 2106 0.00 D 2020-06-15 Ordinary Shares 2106 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020. The option is fully vested and exercisable. /s/ Miles W. McHugh, Attorney-in-Fact 2020-03-31